Blood Pressure Drug Recalled
The recall affects losartan potassium, 50 mg, 60-tablet bottles (NDC 43063-854-60) and 90-tablet bottles (NDC 43063-854-90), from lots A19B99 (Exp. 11/30/19), B19A26 (Exp. 11/30/19), B19A69 (Exp. 11/30/19), E18F12 (Exp. 9/30/19), F18A12 (Exp. 9/30/19), F18F06 (Exp. 9/30/19), G18B43 (Exp. 9/30/19), G18C43 (Exp. 9/30/19), G18F75 (Exp. 9/30/19), H18D55 (Exp. 9/30/19), I18A11 (Exp. 9/30/19), I18E32 (Exp. 9/30/19), J18A90 (Exp. 9/30/19), J18D50 (Exp. 11/30/19), and L18D01 (Exp. 11/30/19).
The recalled products were packaged by PD-Rx Pharmaceuticals, Oklahoma City, OK, and distributed in Alaska, Arizona, California, Colorado, Florida, Kentucky, Massachusetts, Michigan, Minnesota, North Carolina, Ohio, Oregon, Wisconsin, and Wyoming.
PD-Rx Pharmaceuticals voluntarily initiated the recall March 8, 2019. On April 26, 2021, the FDA designated the recalls Class II, communicating use of the drug may cause temporary or medically reversible adverse health consequences or a remote possibility of serious harm.
Losartan is a prescription drug used to treat high blood pressure.
—Jolynn Tumolo